| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |